Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 564 participants.
Also called NCT01167153
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 564 participants
- Sponsor
- Registry
-
NCT01167153
-
- Other papers using this trial's data
- Effects of the valsartan/amlodipine combination and nifedipine gastrointestinal therapeutic system monotherapy on brachial pulse pressure and radial augmentation index in hypertensive patients
- Valsartan/amlodipine compared to nifedipine GITS in patients with hypertension inadequately controlled by monotherapy
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01167153. Randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-04 (actual). Results posted on 2012-06-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
- Acronym
- EXAM
- Condition
- Hypertension
- Intervention (Drug)
- Valsartan/Amlodipine
- Intervention (Drug)
- Nifedipine
- Lead sponsor
- Novartis
Record details
- Record id
cardio:ct-nct01167153- Content hash
d6fbdc8252cdb0bb79a49817fcab1a645cec9b0d8c45b45b36b6e4272f87f88f